Cargando…
Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome
Dravet syndrome (DS) is a rare genetic encephalopathy that is characterized by severe seizures and highly resistant to commonly used antiepileptic drugs (AEDs). In 2020, FDA has approved fenfluramine (FFA) for treatment of seizures associated with DS. However, the clinically used FFA is a racemic mi...
Autores principales: | Li, Jing, Nelis, Maxim, Sourbron, Jo, Copmans, Daniëlle, Lagae, Lieven, Cabooter, Deirdre, de Witte, Peter A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302504/ https://www.ncbi.nlm.nih.gov/pubmed/34041623 http://dx.doi.org/10.1007/s11064-021-03358-2 |
Ejemplares similares
-
Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015) -
Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023) -
Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
por: Sourbron, Jo, et al.
Publicado: (2017) -
In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022) -
Drug repurposing for Dravet syndrome in scn1Lab
(−/−) mutant zebrafish
por: Sourbron, Jo, et al.
Publicado: (2019)